News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
377,743 Results
Type
Article (11146)
Company Profile (58)
Press Release (366537)
Multimedia
Podcasts (36)
Webinars (11)
Section
Business (114664)
Career Advice (615)
Deals (21155)
Drug Delivery (57)
Drug Development (28016)
Employer Resources (55)
FDA (8028)
Job Trends (7832)
News (174725)
Policy (14163)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (892)
Accelerated approval (16)
Adcomms (6)
Allergies (71)
Alliances (25379)
ALS (53)
Alzheimer's disease (624)
Antibody-drug conjugate (ADC) (111)
Approvals (8358)
Artificial intelligence (308)
Autoimmune disease (63)
Automation (16)
Bankruptcy (141)
Best Places to Work (6497)
BIOSECURE Act (4)
Biosimilars (139)
Biotechnology (37)
Bladder cancer (82)
Brain cancer (19)
Breast cancer (278)
Cancer (1973)
Cardiovascular disease (202)
Career advice (542)
Career pathing (5)
CAR-T (96)
CDC (13)
Cell therapy (275)
Cervical cancer (18)
Clinical research (24989)
Collaboration (832)
Compensation (436)
Complete response letters (15)
COVID-19 (991)
CRISPR (36)
C-suite (567)
Cystic fibrosis (52)
Data (2798)
Decentralized trials (1)
Denatured (14)
Depression (57)
Diabetes (230)
Diagnostics (4430)
Digital health (33)
Diversity (5)
Diversity, equity & inclusion (19)
Drug discovery (93)
Drug pricing (94)
Drug shortages (7)
Duchenne muscular dystrophy (104)
Earnings (52311)
Editorial (28)
Employer branding (6)
Employer resources (54)
Events (73573)
Executive appointments (694)
FDA (9774)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (6)
Frontotemporal dementia (13)
Funding (781)
Gene editing (65)
Generative AI (29)
Gene therapy (218)
GLP-1 (380)
Government (1697)
Grass and pollen (4)
Guidances (285)
Healthcare (11575)
HIV (39)
Huntington's disease (10)
IgA nephropathy (38)
Immunology and inflammation (69)
Immuno-oncology (20)
Indications (64)
Infectious disease (1106)
Inflammatory bowel disease (81)
Inflation Reduction Act (8)
Influenza (39)
Intellectual property (83)
Interviews (69)
IPO (10086)
IRA (20)
Job creations (1592)
Job search strategy (489)
JPM (58)
Kidney cancer (13)
Labor market (25)
Layoffs (179)
Leadership (9)
Legal (3525)
Liver cancer (39)
Longevity (7)
Lung cancer (214)
Lymphoma (165)
Machine learning (14)
Management (20)
Manufacturing (316)
MASH (93)
Medical device (8367)
Medtech (8404)
Mergers & acquisitions (11824)
Metabolic disorders (591)
mRNA (70)
Multiple sclerosis (92)
NASH (10)
Neurodegenerative disease (106)
Neuropsychiatric disorders (32)
Neuroscience (1123)
Neurotech (1)
NextGen: Class of 2026 (3812)
Non-profit (2042)
Now hiring (8)
Obesity (257)
Opinion (113)
Ovarian cancer (67)
Pain (75)
Pancreatic cancer (70)
Parkinson's disease (87)
Partnered (16)
Patents (136)
Patient recruitment (196)
Peanut (24)
People (35749)
Pharmaceutical (19)
Pharmacy benefit managers (18)
Phase 1 (6743)
Phase 2 (10180)
Phase 3 (9693)
Pipeline (3460)
Policy (102)
Postmarket research (1136)
Preclinical (2510)
Press Release (67)
Prostate cancer (123)
Psychedelics (9)
Radiopharmaceuticals (165)
Rare diseases (386)
Real estate (2854)
Recruiting (19)
Regulatory (11051)
Reports (24)
Research institute (837)
Resumes & cover letters (84)
Rett syndrome (22)
RNA editing (3)
RSV (31)
Schizophrenia (77)
Series A (132)
Series B (115)
Service/supplier (3)
Sickle cell disease (39)
Special edition (7)
Spinal muscular atrophy (69)
Sponsored (17)
Startups (1870)
Stomach cancer (3)
Supply chain (41)
Tariffs (26)
The Weekly (22)
Vaccines (303)
Venture capital (47)
Weight loss (142)
Women's health (58)
Worklife (3)
Date
Today (155)
Last 7 days (516)
Last 30 days (1563)
Last 365 days (16527)
2026 (2727)
2025 (16774)
2024 (19312)
2023 (21923)
2022 (30508)
2021 (32842)
2020 (32084)
2019 (25870)
2018 (19466)
2017 (16198)
2016 (15739)
2015 (19401)
2014 (14997)
2013 (12304)
2012 (13031)
2011 (13429)
2010 (12346)
Location
Africa (371)
Alabama (35)
Alaska (3)
Arizona (155)
Arkansas (8)
Asia (19607)
Australia (2756)
California (6154)
Canada (1920)
China (463)
Colorado (296)
Connecticut (264)
Delaware (163)
Europe (45362)
Florida (934)
Georgia (180)
Hawaii (2)
Idaho (42)
Illinois (503)
India (63)
Indiana (298)
Iowa (11)
Japan (285)
Kansas (54)
Kentucky (29)
Louisiana (22)
Maine (75)
Maryland (662)
Massachusetts (4561)
Michigan (197)
Minnesota (382)
Mississippi (3)
Missouri (97)
Montana (21)
Nebraska (17)
Nevada (72)
New Hampshire (40)
New Jersey (1936)
New Mexico (10)
New York (1684)
North Carolina (908)
North Dakota (5)
Northern California (3182)
Ohio (205)
Oklahoma (10)
Oregon (17)
Pennsylvania (1311)
Puerto Rico (6)
Rhode Island (24)
South America (516)
South Carolina (27)
Southern California (2322)
Tennessee (118)
Texas (840)
United States (22640)
Utah (251)
Virginia (143)
Washington D.C. (44)
Washington State (504)
West Virginia (3)
Wisconsin (90)
Wyoming (2)
377,743 Results for "tenet healthcare corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
UCI Health Reaches Definitive Agreement to Acquire Four Southern California Hospitals From Tenet Healthcare Corporation
The Regents of the University of California, on behalf of the University of California, Irvine, has entered into a definitive agreement with Tenet Healthcare Corporation to acquire Tenet’s Pacific Coast Network.
February 1, 2024
·
6 min read
Deals
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Eliem Therapeutics, Inc. (Nasdaq: ELYM) (“Eliem”), today announced the closing of its acquisition with Tenet Medicines (“Tenet”).
June 27, 2024
·
11 min read
Deals
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Eliem Therapeutics, Inc. and Tenet Medicines, Inc., a development-stage private biotechnology company, announced that the companies have entered into a definitive acquisition agreement whereby Eliem has agreed to acquire Tenet.
April 11, 2024
·
14 min read
Press Releases
Bruker Corporation to Present at the J.P. Morgan Healthcare Conference
January 8, 2026
·
1 min read
Press Releases
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
December 19, 2025
·
1 min read
Press Releases
Repligen Corporation to Present at Evercore Healthcare Conference
November 27, 2025
·
1 min read
Press Releases
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
2 min read
Press Releases
Alkeus Pharmaceuticals to Present Corporate Update at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
·
1 min read
Press Releases
Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference
January 12, 2026
·
8 min read
Press Releases
Waters Corporation to Present at the Jefferies Global Healthcare Conference 2025 in London
November 11, 2025
·
1 min read
1 of 37,775
Next
